JUPITER NEUROSCIENCES, INC.
JUNSNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for JUNS. That does not mean none is planned.
Get an email about JUNS's next catalysts
Track JUPITER NEUROSCIENCES (JUNS) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
JUNS Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
How JUNS's past catalysts played out
Market Overview
Stock performance and key metrics
Trans-Resveratrol
Parkinson's Disease
Oxygen at 1.5 ATA (atmospheres absolute)
Traumatic Brain Injury
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Trans-Resveratrol | Phase 2 | Parkinson's Disease | - | - |
Oxygen at 1.5 ATA (atmospheres absolute) | Phase 2 | Traumatic Brain Injury | - | - |
Frequently asked questions
What is in JUPITER NEUROSCIENCES, INC.'s drug pipeline?β
CatalystAlert tracks 2 drug candidates in JUPITER NEUROSCIENCES, INC.'s (JUNS) pipeline across Phase 2. Its lead program is Oxygen at 1.5 ATA (atmospheres absolute) (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is JUPITER NEUROSCIENCES, INC.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for JUPITER NEUROSCIENCES, INC. (JUNS) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track JUNS biotech catalysts?β
Add JUNS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow JUPITER NEUROSCIENCES, INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
